The SLAS Ignite Award recognises the best start-up or emerging company exhibiting within Innovation AveNEW, the specially designated area for start-ups and emerging companies within the SLAS Europe 2021 Exhibition, European Sample Management Symposium or AI-Powered Drug Discovery Symposium.
Companies selected for Innovation AveNEW, and who opt-in to compete for the SLAS Ignite Award, will be judged by an SLAS panel on a combination of key concepts, including their marketing plan, market presence and potential; funding prospect; plan for growth and the existence of balanced company leadership, among other qualities.
This will be the first year of the Ignite Award winner for the SLAS Europe Conference and Exhibition.
All Innovation AveNEW participating companies are invited to opt-in to consideration for the SLAS Ignite Award.
Deadline for SLAS Europe 2021 Innovation AveNEW Applicants — Monday, 7 June
Announcement of SLAS Europe 2021 Innovation AveNEW companies — Monday, 14 June
SLAS Europe 2021 Deadline for Opt-In for the Ignite Award — Monday, 21 June
Announcement of SLAS Europe 2021 Finalists for Ignite Award — July 2021
Deadline for European Sample Management Symposium and AI-Powered Drug Discovery Symposium Innovation AveNEW — Monday, 27 September
Announcement of Selected Innovation AveNEW companies for European Sample Management Symposium and AI-Powered Symposium — Monday, 11 October
Eureopean Sample Management Symposium and AI-Powered Drug Discovery Symposium deadline for Opt-In for the Ignite Award — Friday, 15 October
Announcement of Finalists for Ignite Award from European Sample Management Symposium and AI-Powered Drug Discovery Symposium — Saturday, 30 October
Judging will take place virtually after the conference and at the SLAS European Sample Management Symposium and AI-Powered Drug Discovery Symposium. The award winner will be announced in December 2021 and will give a presentation at SLAS2022.
A panel of judges will visit the digital booths and meet with each company’s representative. Judging visits will be scheduled with each booth individually.
There must always be AT LEAST ONE person at the booth during the judging period who can discuss the company’s mission with the judges.
The judging panel’s decision will be based on a series of criteria (in no order of significance) evaluated through presentations at the company’s booth and in the Exhibition Theater:
5-to-1 Rating Scale:
5 — Outstanding, Novel and Broad Impact for a New Product
4 — Very Good, Solid, Novel Product
3 — Some Unique New Product Qualities
2 — Needs More Proof and Development
1 — Not Substantially New or Improved
All companies who are chosen to exhibit in Innovation AveNEW are eligible to compete for the SLAS Ignite Award. Innovation AveNEW companies must align in some fashion with the area of life sciences and technology, and while it is not required, an established relationship with a university, bioscience incubator or research institution is preferable. The company’s products and/or services must be available for sale/distribution in the year of their conference participation.
Discrimination based on race, religion, gender, age, national origin, ethnicity, veteran status or disability in regard to the SLAS Ignite Award designation is prohibited. Each candidate company shall be evaluated based on the award's criteria, which are tied to SLAS's purpose of advancing science and education through technology in the laboratory.
SLAS reserves the right to select and deselect any company at any given time. All decisions are final.
Questions? Contact Elizabeth Frank, Program Manager or at +1.630.256.SLAS (7527) ext. 102.